{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.11.1086","meta":{"versionId":"28","lastUpdated":"2021-02-20T01:00:45.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086","version":"20210220","name":"Measles, Mumps and Rubella (MMR) Vaccine Administered","status":"active","date":"2021-02-20T01:00:45-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"150971000119104","display":"Measles, mumps and rubella vaccination given (situation)"},{"code":"170433008","display":"Administration of second dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"code":"38598009","display":"Administration of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"code":"432636005","display":"Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"code":"433733003","display":"Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"code":"571591000119106","display":"Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"code":"572511000119105","display":"Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"}]}]}}